Mojave Brands Inc.

MOJO

CA6083842022

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:08:25 2024-04-19 pm EDT			5-day change	1st Jan Change
0.325 ^CAD	+1.56%		+1.56%	-35.00%

Apr. 19	Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
Feb. 05	Mojave Brands Inc. announced that it expects to receive CAD 7.5 million in funding	CI

Mojave Brands Inc. Reports Earnings Results for the Full Year Ended August 31, 2022

December 22, 2022

Mojave Brands Inc. reported earnings results for the full year ended August 31, 2022. For the full year, the company reported net income was CAD 0.067119 million compared to net loss of CAD 0.18859 million a year ago.

Latest news about Mojave Brands Inc.

Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Apr. 18	CI
Mojave Brands Inc. announced that it expects to receive CAD 7.5 million in funding	Feb. 04	CI
Light AI Inc. entered into a binding letter of intent to acquire Mojave Brands Inc. (CNSX : MOJO) for CAD 15.89 million in a reverse merger transaction.	Feb. 04	CI
Light AI Inc. announced that it expects to receive CAD 7.5 million in funding from Mojave Brands Inc.	Jan. 30	CI
Mojave Brands Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	Jan. 28	CI
Mojave Brands Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Dec. 20	CI
Mojave Brands Inc. announced that it has received CAD 0.475986 million in funding	Dec. 14	CI
Mojave Brands Inc. announced that it expects to receive CAD 0.8855 million in funding	Dec. 05	CI
Mojave Brands Inc. Announces Chief Financial Officer Changes	23-09-26	CI
Mojave Brands Inc. Announces Chief Executive Officer Changes	23-09-26	CI
Mojave Brands Inc. Announces Board Changes	23-09-26	CI
Mojave Brands Inc. Announces Board Changes	23-09-19	CI
Mojave Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-07-31	CI
Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-05-01	CI
Mojave Brands Inc. Announces Resignation of Satnam Brar from the Board of Directors	23-02-23	CI
Mojave Brands Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-30	CI
Mojave Brands Inc. Auditor Raises 'Going Concern' Doubt	22-12-22	CI
Mojave Brands Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22-12-22	CI
Mojave Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	22-07-26	CI
Mojave Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	22-04-21	CI
Mojave Brands Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	22-01-20	CI
Mojave Brands Inc. Auditor Raises 'Going Concern' Doubt	21-12-16	CI
Mojave Brands Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	21-12-16	CI
Mojave Brands Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	21-07-19	CI
Mojave Brands Inc. announced that it has received CAD 0.69 million in funding	21-07-11	CI

Chart Mojave Brands Inc.

Duration

Period

More charts

Company Profile

Mojave Brands Inc. is a Canada-based company. The Company's principal business was the manufacturing, processing and sale of cannabis extracts. The Company is not generating revenues as it has closed down all its operations in the United States, and plans to seek out other potential strategic alliances, joint venture, acquisitions, or merger opportunities.

Sector

Pharmaceuticals

Calendar

2024-07-30 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MOJAVE BRANDS INC.	-35.00%	2.19M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B